← Evidence map

ArticleAnnals of internal medicine2023

Correction: Apixaban Versus Rivaroxaban in Patients With Atrial Fibrillation and Valvular Heart Disease.

PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 37487217